• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2012年加利福尼亚州医用大麻的使用情况

Prevalence of medical marijuana use in California, 2012.

作者信息

Ryan-Ibarra Suzanne, Induni Marta, Ewing Danielle

机构信息

Survey Research Group, Public Health Institute, Sacramento, California, USA.

出版信息

Drug Alcohol Rev. 2015 Mar;34(2):141-6. doi: 10.1111/dar.12207. Epub 2014 Sep 26.

DOI:10.1111/dar.12207
PMID:25255903
Abstract

INTRODUCTION AND AIMS

The US Drug Enforcement Agency classifies marijuana as an illegal substance, yet in 22 states marijuana is legal for medicinal use. In 1996, California legalised the use of marijuana for medicinal purposes, but population-based data describing medical marijuana users in the state has not been available. Our aim was to examine the demographic differences between users and non-users of medical marijuana in California utilising population-based data.

DESIGN AND METHODS

We used data from the California Behavioral Risk Factor Surveillance System 2012, an annual, random-digit-dial state-wide telephone survey that collects health data from a representative adult sample (n = 7525). Age-adjusted prevalence rates were estimated.

RESULTS

Five percent of adults in California reported ever using medical marijuana, and most users believed that medical marijuana helped alleviate symptoms or treat a serious medical condition. Prevalence was similar when compared by gender, education and region. Prevalence of ever using medical marijuana was highest among white adults and younger adults ages 18-24 years, although use was reported by every racial/ethnic and age group examined in our study and ranged from 2% to 9%.

CONCLUSIONS

Our study's results lend support to the idea that medical marijuana is used equally by many groups of people and is not exclusively used by any one specific group. As more states approve marijuana use for medical purposes, it is important to track medical marijuana use as a health-related behaviour and risk factor.

摘要

引言与目的

美国缉毒局将大麻归类为非法物质,但在22个州大麻用于医疗用途是合法的。1996年,加利福尼亚州将大麻用于医疗目的合法化,但该州缺乏基于人群描述医用大麻使用者的数据。我们的目的是利用基于人群的数据研究加利福尼亚州医用大麻使用者与非使用者之间的人口统计学差异。

设计与方法

我们使用了2012年加利福尼亚行为风险因素监测系统的数据,这是一项每年进行的全州随机数字拨号电话调查,从具有代表性的成年样本(n = 7525)中收集健康数据。估计了年龄调整患病率。

结果

加利福尼亚州5%的成年人报告曾使用过医用大麻,大多数使用者认为医用大麻有助于缓解症状或治疗严重疾病。按性别、教育程度和地区比较时,患病率相似。曾使用医用大麻的患病率在白人成年人和18 - 24岁的年轻成年人中最高,尽管我们研究中调查的每个种族/族裔和年龄组都有使用报告,范围从2%到9%。

结论

我们研究的结果支持这样一种观点,即许多人群都平等地使用医用大麻,并非仅由任何一个特定群体使用。随着更多州批准将大麻用于医疗目的,将医用大麻使用作为一种与健康相关的行为和风险因素进行追踪很重要。

相似文献

1
Prevalence of medical marijuana use in California, 2012.2012年加利福尼亚州医用大麻的使用情况
Drug Alcohol Rev. 2015 Mar;34(2):141-6. doi: 10.1111/dar.12207. Epub 2014 Sep 26.
2
Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users.医用大麻使用者自我报告的大麻使用特征、模式及效用。
Am J Drug Alcohol Abuse. 2014 Jan;40(1):23-30. doi: 10.3109/00952990.2013.821477. Epub 2013 Nov 8.
3
Use of marijuana exclusively for medical purposes.专用于医疗目的的大麻使用。
Drug Alcohol Depend. 2019 Feb 1;195:13-15. doi: 10.1016/j.drugalcdep.2018.11.009. Epub 2018 Dec 4.
4
Correlates of Marijuana Drugged Driving and Openness to Driving While High: Evidence from Colorado and Washington.大麻影响下驾驶的相关因素及对在吸食大麻状态下驾驶的接受度:来自科罗拉多州和华盛顿州的证据。
PLoS One. 2016 Jan 22;11(1):e0146853. doi: 10.1371/journal.pone.0146853. eCollection 2016.
5
Toking, Vaping, and Eating for Health or Fun: Marijuana Use Patterns in Adults, U.S., 2014.为健康或娱乐而吸食、吸电子烟及食用大麻:2014年美国成年人的大麻使用模式
Am J Prev Med. 2016 Jan;50(1):1-8. doi: 10.1016/j.amepre.2015.05.027. Epub 2015 Aug 12.
6
Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys.1991年至2014年美国医用大麻法律与青少年大麻使用情况:年度重复横断面调查结果
Lancet Psychiatry. 2015 Jul;2(7):601-8. doi: 10.1016/S2215-0366(15)00217-5. Epub 2015 Jun 15.
7
Perceived support for medical cannabis use among approved medical cannabis users in Canada.加拿大已批准的医用大麻使用者对医用大麻使用的感知支持度。
Drug Alcohol Rev. 2018 Jul;37(5):627-636. doi: 10.1111/dar.12823. Epub 2018 Jun 5.
8
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users.《2012/13年新西兰健康调查:药用大麻使用者的特征》
N Z Med J. 2016 Apr 22;129(1433):25-36.
9
Adolescents' Use of Medical Marijuana: A Secondary Analysis of Monitoring the Future Data.青少年对医用大麻的使用:对“监测未来”数据的二次分析
J Adolesc Health. 2015 Aug;57(2):241-4. doi: 10.1016/j.jadohealth.2015.04.008.
10
Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder.对医用大麻项目的宽松监管与成年人更高的大麻使用率相关,但与大麻使用障碍无关。
Addiction. 2017 Nov;112(11):1985-1991. doi: 10.1111/add.13904. Epub 2017 Jul 17.

引用本文的文献

1
Medicinal and combined medicinal/recreational cannabis use in California following the passage of Proposition 64.加利福尼亚州第64号提案通过后医用大麻及医用/娱乐用大麻的联合使用情况
J Cannabis Res. 2025 Jul 12;7(1):44. doi: 10.1186/s42238-025-00285-9.
2
Emerging trends in cannabis administration for women with chronic pain.慢性疼痛女性使用大麻的新趋势。
Mental Health Sci. 2024 Dec;2(4). doi: 10.1002/mhs2.88. Epub 2024 Sep 24.
3
Discussions of Cannabis Over Patient Portal Secure Messaging: Content Analysis.通过患者门户安全消息功能对大麻相关讨论的内容分析
J Med Internet Res. 2024 Dec 12;26:e63311. doi: 10.2196/63311.
4
Egocentric Network Characteristics and Cannabis Use in a Sample of Young Adult Medical Cannabis Patients and Nonpatient Users.以自我为中心的网络特征与年轻成人医用大麻患者和非患者使用者中的大麻使用情况。
J Stud Alcohol Drugs. 2022 Nov;83(6):802-811. doi: 10.15288/jsad.21-00286.
5
Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain.大麻二酚与Δ9-四氢大麻酚在慢性炎性痛雄性和雌性大鼠体内的相互作用
J Pain. 2023 Jan;24(1):98-111. doi: 10.1016/j.jpain.2022.09.002. Epub 2022 Sep 16.
6
Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients.比较初级保健患者在机密调查中报告的医疗大麻使用情况与电子健康记录中记录的情况。
JAMA Netw Open. 2022 May 2;5(5):e2211677. doi: 10.1001/jamanetworkopen.2022.11677.
7
Clinical documentation of patient-reported medical cannabis use in primary care: Toward scalable extraction using natural language processing methods.临床记录患者在初级保健中使用医用大麻的情况:使用自然语言处理方法实现可扩展的提取。
Subst Abus. 2022;43(1):917-924. doi: 10.1080/08897077.2021.1986767.
8
Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective Study.医用大麻的依从性、安全性和有效性以及患者群体的流行病学特征:一项前瞻性研究。
Front Med (Lausanne). 2022 Feb 9;9:827849. doi: 10.3389/fmed.2022.827849. eCollection 2022.
9
Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State.在华盛顿州的初级保健患者的电子健康记录中记录的医用大麻使用和相关健康状况的流行率。
JAMA Netw Open. 2021 May 3;4(5):e219375. doi: 10.1001/jamanetworkopen.2021.9375.
10
Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015-2019).用于纤维肌痛疼痛的大麻素:对近期研究(2015 - 2019年)的批判性综述
J Cannabis Res. 2020 May 29;2(1):19. doi: 10.1186/s42238-020-00024-2.